According to a new market report published by Transparency Market Research, the global bovine blood plasma derivatives market was valued at US$ 1,338.9 Mn in 2016 and is expected to grow at a high CAGR of 5.8% from 2017 to 2025, to reach an estimated value of US$ 2,196.8 Mn in 2025.
The report on global bovine blood plasma derivatives market has been classified on the basis of three categories by derivatives type, by application, and geography (regions & countries). Major application segment include food industry, cell culture/ biotechnology, pharmaceutical industry, research and development, cosmetic industry, diagnostic industry, and others. The derivatives type segment includes immunoglobulin, fibrinogen, bovine serum albumin, fetal bovine serum, thrombin, transferrin, new born calf serum, and others (BGG, etc.). The report offers a detailed description behind the steady growth rate of the market and a possible growth trajectory at the global as well as regional level in terms of value and the market share for each bovine blood derivatives segment. The report is thus, compiled with the prime intent of updating the stakeholders with the incumbent market dynamics through a graphical illustration and in-depth analysis of each segment considered within the study scope.
Geographically, the report has been segmented into five regions: North America, Europe, Asia, Latin America and Middle East & Africa. These regions are further segmented into major national markets such as in North America (U.S. and Canada), Europe (U.K., Germany, Italy, Spain, France, Russia, and Rest of Europe), Asia Pacific (China, India, Australia, New Zealand), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of MEA).
North America leads the global bovine blood plasma derivatives market commanding more than 30% share in the global market in 2015. Demand for bovine blood plasma derivatives is the highest in the U.S., which held around 87.1% market share in 2015. Higher share of the U.S. is attributed to the presence of a large number of industries such as food, nutrition, and pharmaceutical. Growth of the market in this region is driven by major industry participants in North America who continue to focus on innovating cell culture applications and the diversity of different cell lines and their cellular interactions to develop different cell cultures. In addition, the use of bovine blood plasma derivatives is rapid increasing in applications such as sports nutrition and pet food industry. Also, North America is expected to dominate the market in the forecast period due to early availability of advanced technologies for blood fractionation and increased import of Australia and New Zealand live cattle animals which further utilized for manufacturing of plasma products and derivatives.
Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39818
Asia Pacific held the second largest market share in 2015 with contribution of around 21.8% in 2015. Demand for bovine blood plasma derivatives is highest in Australia, which held around 23.3% market share in 2015, followed by New Zealand and China. Bovine blood plasma derivatives manufacturers are broadly distributed throughout Asia Pacific. Also, Asia Pacific is a relatively untapped market than the developed regions. Hence, the region presents better opportunity for growth in this market. Europe held the third largest market share in 2015 with contribution of around 20.1% in 2015. Europe is the third leading market due to high demand in food industry of developed countries such as U.K., Germany, and France. Demand for bovine blood plasma derivatives in countries such as Spain, France, Denmark, and the Netherlands is also increasing gradually. Germany is considered a highly promising market for bovine blood plasma derivatives due to increased use of advanced technology advanced process for blood collections and fractionation. Additionally, rising demand in applications such as pet food industry, cosmetic industry and nutrition supplements is driving the market in the region. In Latin America, Brazil is the key market which accounted for the largest share of the bovine blood plasma derivatives market in Latin America. Recent economic development and ongoing investments in various manufacturing facilities within the country would contribute largely to the growth of this market in the region.
The key players operating in the bovine blood plasma derivatives market are Proliant Inc., Bovogen Biologicals Pty Ltd., LAMPIRE Biological Laboratories, Inc., Rocky Mountain Biologicals Inc., Thermo Fisher Scientific, Inc., Sigma-Aldrich Co. (Merck KGaA), Kraeber & Co GmbH, Auckland BioSciences Ltd., Lake Immunogenics, Inc., etc. The bovine blood plasma derivatives market is fragmented with presence of many small scale and large scale vendors that operates in the global market. However, the global bovine blood plasma derivatives market is dominated only by few players that operates in global market.